Blue Bird (NASDAQ: BLBD) insider transactions
In the twelve months to 10 November 2026, executives and directors of Blue Bird reported 7 open-market sales of 43,488 shares ($2.3m) and 3 open-market purchases of 1,050 shares ($62,477), by 4 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 16 September 2026 | Sanfrey Jeffrey Scott | Chief Operating Officer | Open-market sale | −4,000 | $62.40 | 35,011 | Form 4 |
| 12 August 2026 | Thau Daniel Mark | Director | Open-market purchase | +350 | $64.37 | 9,046 | Form 4 |
| 19 May 2026 | Thau Daniel Mark | Director | Open-market purchase | +300 | $65.09 | 8,696 | Form 4 |
| 1 April 2026 | Girardin Steve | Director | Grant or award | +1 | — | 1 | Form 4 |
| 1 April 2026 | Girardin Steve | Director | Grant or award | +2,297 | — | 2,297 | Form 4 |
| 1 April 2026 | Fream Julie A | Director | Grant or award | +2,297 | — | 9,705 | Form 4 |
| 1 April 2026 | Blaufuss Mark | Director | Grant or award | +2,297 | — | 10,334 | Form 4 |
| 1 April 2026 | Penn Kevin S. | Director | Grant or award | +2,297 | — | 6,396 | Form 4 |
| 1 April 2026 | Grimm Douglas J. | Director | Grant or award | +2,297 | — | 28,764 | Form 4 |
| 1 April 2026 | Hightower Edward T. | Director | Grant or award | +2,297 | — | 6,396 | Form 4 |
| 1 April 2026 | Newman Simon J | Director | Grant or award | +2,297 | — | 10,334 | Form 4 |
| 1 April 2026 | Thau Daniel Mark | Director | Grant or award | +2,297 | — | 8,396 | Form 4 |
| 4 March 2026 | Sanfrey Jeffrey Scott | Chief Operating Officer | Option exercise | +5,192 | $12.35 | 44,203 | Form 4 |
| 4 March 2026 | Sanfrey Jeffrey Scott | Chief Operating Officer | Open-market sale | −5,192 | $58.54 | 39,011 | Form 4 |
| 19 February 2026 | Radulescu Razvan | Chief Financial Officer | Open-market sale | −3,925 | $60.98 | 42,255 | Form 4 |
| 17 December 2025 | Radulescu Razvan | Chief Financial Officer | Option exercise, 10b5-1 plan | +3,503 | $12.35 | 49,683 | Form 4 |
| 17 December 2025 | Radulescu Razvan | Chief Financial Officer | Option exercise, 10b5-1 plan | +3,503 | $12.35 | 53,186 | Form 4 |
| 17 December 2025 | Radulescu Razvan | Chief Financial Officer | Open-market sale, 10b5-1 plan | −7,006 | $51.58 | 46,180 | Form 4 |
| 12 December 2025 | Horlock Phil | Director | Open-market sale | −7,040 | $50.50 | 233,726 | Form 4 |
| 12 December 2025 | Horlock Phil | Director | Open-market sale | −8,341 | $50.35 | 225,385 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Blue Bird page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.